The researchers examined trends in health care for eating disorders from 2018 to 2020, together with other common behavioral health conditions, in a section of commercially insured individuals in the United States.
The aim of this study was to understand the relation between changes in behavior and mental health during the early phase of the first wave of the COVID-19 pandemic in the United States during April and May, 2020.
In this study, patients were stratified by condition and suicide history and randomized to receive 600 mg/d extended-release lithium carbonate or placebo in addition to usual care.
This study is the first to examine gender differences in work-family conflict and wellbeing in a cohort of physician parents before and during the COVID-19 pandemic.
Researchers examined the association of the use of the placebo run-in period with the placebo response, drug response, and drug-placebo difference among randomized clinical trials of antidepressants.
The approval was supported by data from two phase 3 studies that evaluated Caplyta as monotherapy and adjunctive therapy with lithium or valproate in adults with bipolar depression.
This study examines patient preferences for physicians with cultural competency among patients with depression and anxiety.
Psychiatrists and other mental health professionals are increasingly being asked to write letters certifying patients’ and clients’ animals as emotional support animals.
Researchers performed a secondary analysis of the AFFINITY trial that assessed the effects of fluoxetine treatment on depression symptoms in patients who recently had a stroke.
The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to targeted areas of the brain.
